Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-06-05 4:48 pm Sale | 13D | ITERUM THERAPEUTICS PLC SHS NE ITRM | Sofinnova Venture Partners IX L.P. | 6,154 0% | -1,726,514 (-99.64%) | View |
| 2020-06-05 4:31 pm Sale | 13D | ITERUM THERAPEUTICS LTD ITRM | Arix Bioscience plc | 329,193 2.2% | -766,864 (-69.97%) | View |
| 2020-01-29 4:39 pm Purchase | 13D | ITERUM THERAPEUTICS LTD ITRM | Advent Life Sciences LLP | 879,402 5.9% | 11,241 (+1.29%) | View |
| 2020-01-27 5:21 pm Purchase | 13D | ITERUM THERAPEUTICS LTD ITRM | Arix Bioscience plc | 1,096,057 7.4% | 64,154 (+6.22%) | View |
| 2020-01-27 5:00 pm Unchanged | 13D | ITERUM THERAPEUTICS LTD ITRM | Frazier Healthcare VII L.P. | 1,538,316 10.3% | 0 (Unchanged) | View |
| 2020-01-27 4:39 pm Purchase | 13D | ITERUM THERAPEUTICS LTD ITRM | New Leaf Venture Management III L.L.C. | 1,467,544 9.9% | 11,241 (+0.77%) | View |
| 2020-01-24 9:51 pm Purchase | 13D | ITERUM THERAPEUTICS PLC SHS NE ITRM | Sofinnova Venture Partners IX L.P. | 1,732,668 11.6% | 6,154 (+0.36%) | View |